FDA Approved: DIHYDROERGOTAMINE MESYLATE NASAL — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla's dihydroergotamine mesylate nasal spray as an original generic application, making a generic version of the acute migraine treatment ava…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dihydroergotamine Mesylate Nasal (dihydroergotamine mesylate nasal spray)

Snippet

ORIG AP for DIHYDROERGOTAMINE MESYLATE NASAL (DIHYDROERGOTAMINE MESYLATE NASAL)